{
    "Trade/Device Name(s)": [
        "ProFlu+ Assay",
        "ProFluTM Plus"
    ],
    "Submitter Information": "Prodesse, Inc.",
    "510(k) Number": "K073029",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC"
    ],
    "Summary Letter Date": "October 25, 2007",
    "Summary Letter Received Date": "October 26, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A Virus",
        "Influenza B Virus",
        "Respiratory Syncytial Virus (RSV)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Polyester swab",
        "Rayon swab",
        "Nylon tipped swab",
        "Viral transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid SmartCycler II",
        "MagNA Pure LC Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Real Time RT-PCR",
        "Taqman chemistry",
        "Nucleic acid isolation"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Detection system",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Prodesse ProFlu+ multiplex RT-PCR assay for detection of Influenza A, Influenza B, and RSV from nasopharyngeal swab specimens",
    "Indications for Use Summary": "Multiplex Real Time RT-PCR in vitro diagnostic test for rapid and qualitative detection and discrimination of Influenza A Virus, Influenza B Virus, and RSV nucleic acids from nasopharyngeal swabs of symptomatic patients; aids differential diagnosis of viral infections in humans, not intended to detect Influenza C",
    "fda_folder": "Microbiology"
}